
Programmed death 1 Ligand 1 expression in breast cancer and its association with patients' clinical parameters
Author(s) -
Fēi Li,
Yi Ren,
Zhandong Wang
Publication year - 2018
Publication title -
journal of cancer research and therapeutics/journal of cancer research and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.475
H-Index - 39
eISSN - 0973-1482
pISSN - 1998-4138
DOI - 10.4103/jcrt.jcrt_602_17
Subject(s) - medicine , breast cancer , immunohistochemistry , grading (engineering) , breast carcinoma , oncology , cancer , pathology , ductal carcinoma , biology , ecology
To evaluate the expression of programmed death 1 ligand 1 (PD-L1) in the cancer tissues and tumor-adjacent normal tissues of patients with invasive ductal carcinoma of the breast and to analyze the relationship between the expression of PD-L1 and the clinicopathological features of patients.